• Weak to moderate complete membrane staining observed in >10% of tumor cells. • Basolateral staining for HER2 in a rare subtype of breast cancer with micropapillary histology and circumferential staining that is intense but <10% or the tumor cells. This evidence concerns the gene ERBB2 and neoplasm.